Avanza Fonder Ab Harmony Biosciences Holdings, Inc. Transaction History
Avanza Fonder Ab
- $3.05 Trillion
- Q1 2025
A detailed history of Avanza Fonder Ab transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Avanza Fonder Ab holds 2,924 shares of HRMY stock, worth $100,088. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,924
Previous 4,200
30.38%
Holding current value
$100,088
Previous $145 Million
34.18%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding HRMY
# of Institutions
275Shares Held
44.6MCall Options Held
130KPut Options Held
46.5K-
Valor Management LLC Chicago, IL6.62MShares$227 Million91.68% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$200 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.7MShares$161 Million0.0% of portfolio
-
State Street Corp Boston, MA1.58MShares$54.1 Million0.0% of portfolio
-
American Century Companies Inc Kansas City, MO1.29MShares$44.1 Million0.03% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $2.03B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...